| Literature DB >> 34253612 |
María Carolina Gonzalez1, Janine I Rossato1, Andressa Radiske1, Lia R M Bevilaqua1, Martín Cammarota2.
Abstract
Consolidation and reconsolidation are independent memory processes. Consolidation stabilizes new memories, whereas reconsolidation restabilizes memories destabilized when reactivated during recall. However, the biological role of the destabilization/reconsolidation cycle is still unknown. It has been hypothesized that reconsolidation links new information with reactivated memories, but some reports suggest that new and old memories are associated through consolidation mechanisms instead. Object-recognition memory (ORM) serves to judge the familiarity of items and is essential for remembering previous events. We took advantage of the fact that ORM consolidation, destabilization, and reconsolidation can be pharmacologically dissociated to demonstrate that, depending on the activation state of hippocampal dopamine D1/D5 receptors, the memory of a novel object presented during recall of the memory of a familiar one can be formed via reconsolidation or consolidation, but only reconsolidation can link them. We also found that recognition memories formed through reconsolidation can be destabilized even if indirectly reactivated. Our results indicate that dopamine couples novelty detection with memory destabilization to determine whether a new recognition trace is associated with an active network and suggest that declarative reminders should be used with caution during reconsolidation-based psychotherapeutic interventions.Entities:
Keywords: CaMKII; PKMζ; indirect recall; memory schemata; memory updating
Mesh:
Substances:
Year: 2021 PMID: 34253612 PMCID: PMC8307459 DOI: 10.1073/pnas.2025275118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Fig. 1.Dopamine D1/D5 receptors control whether ORMs are linked through reconsolidation. (A, Top) Experimental protocol. (Middle) One day after training (TR) with objects A and B, animals received vehicle (VEH) or SCH23390 (SCH) in dorsal-CA1 and 20 min later were subjected to an ORM reactivation session (RA) in the presence of familiar object A and novel object C. Five min later, animals received VEH, anisomycin (ANI), AIP, or ZIP in CA1. Retention was evaluated one day later by reexposing animals to objects A, B, or C alongside novel object D (test session; ANI: AD, t(18) = 3.546, P = 0.0023; AIP: CD, t(18) = 3.123, P = 0.0059; ZIP: AD, t(18) = 4.623, P = 0.0002, CD, t(18) = 2.823, P = 0.0113). (Bottom) Total exploration time at TR, RA, and test. (B) Rats were treated as in A, but received VEH or ANI 3 h post-RA. (C) Rats were treated as in A, but received VEH, scrambled-AIP (sAIP), or scrambled-ZIP (sZIP) 5 min post-RA. (D, Top) Experimental protocol. (Middle) Twenty-four hours post-TR, rats received VEH or SCH in dorsal-CA1 and 20 min later were subjected to a 5-min-long ORM reactivation session (RA1) during which they explored familiar object A and novel object C. One day later, animals were reexposed to object C alongside novel object D for 5 min (RA2) and 5 min later received VEH or ANI in dorsal-CA1. Retention was assessed 24 h later by reexposing animals to objects A, B, C, or D alongside novel object E (test session; ANI: AE, t(17) = 3.010, P = 0.0079). (D, Bottom) Total exploration time at TR, RAs, and test. Data are presented as mean ± SEM; n = 8 to 11 animals/group; #P < 0.05 in one-sample t test; *P < 0.05, **P < 0.01, ***P < 0.001 in unpaired t test.